Reversible bioprosthetic valve thrombosis from eosinophilia

BMJ Case Rep. 2018 Feb 8:2018:bcr2017222937. doi: 10.1136/bcr-2017-222937.

Abstract

A 31-year-old man with a mitral bioprosthetic valve presented with recent worsening of exertional dyspnoea 7 years after the mitral valve replacement. Evaluation revealed an increased gradient across the thickened mitral bioprosthetic valve leaflets. Marked eosinophilia was present and was considered as a putative cause for bioprosthetic valve thrombosis. The treatment with systemic corticosteroids and oral anticoagulation led to complete resolution of symptoms with significant decrease in mitral bioprosthetic valve gradient and leaflet thinning. The case is reported to highlight the fact that eosinophilia may cause reversible bioprosthetic valve thrombosis.

Keywords: cardiovascular medicine; valvar diseases.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Anticoagulants / therapeutic use
  • Diethylcarbamazine
  • Echocardiography
  • Heart Valve Prosthesis*
  • Humans
  • Hypereosinophilic Syndrome / blood
  • Hypereosinophilic Syndrome / complications*
  • Hypereosinophilic Syndrome / drug therapy
  • Male
  • Mitral Valve / diagnostic imaging*
  • Mitral Valve / surgery
  • Prosthesis Failure / adverse effects*
  • Radiography
  • Reoperation
  • Thrombosis / diagnostic imaging
  • Thrombosis / drug therapy
  • Thrombosis / etiology*

Substances

  • Adrenal Cortex Hormones
  • Anticoagulants
  • Diethylcarbamazine